235 related articles for article (PubMed ID: 22377693)
1. First-trimester screening for neural tube defects using alpha-fetoprotein.
Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
[TBL] [Abstract][Full Text] [Related]
2. [Increased AFP in maternal serum as an indication for invasive diagnosis].
Gremm B; Sohn C; Beldermann F; Bastert G
Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
Milunsky A; Alpert E; Neff RK; Frigoletto FD
Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum α-fetoprotein at 11-13 weeks' gestation in spontaneous early preterm delivery.
Beta J; Bredaki FE; Rodriguez Calvo J; Akolekar R; Nicolaides KH
Fetal Diagn Ther; 2011; 30(2):88-93. PubMed ID: 21411977
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
[TBL] [Abstract][Full Text] [Related]
6. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Sancken U; Bartels I
Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
[TBL] [Abstract][Full Text] [Related]
7. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
Schlosser H; Greiff R
Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
Chen CP
Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
[TBL] [Abstract][Full Text] [Related]
10. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA
Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990
[TBL] [Abstract][Full Text] [Related]
11. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
[TBL] [Abstract][Full Text] [Related]
12. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
[TBL] [Abstract][Full Text] [Related]
13. [Results of an experiment in systematic prenatal screening for neural tube malformations by assay of alpha fetoproteins in dried blood samples (12,480 pregnancies)].
Augier D; Sarramon MF; Rorive C; Dutau G; Sablayrolles B; Reme JM; Rochiccioli P
J Genet Hum; 1985 Sep; 33(3-4):325-36. PubMed ID: 2414398
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
Nadler HL; Simpson JL
Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
[TBL] [Abstract][Full Text] [Related]
15. First-trimester screening for trisomy 21 using alpha-fetoprotein.
Bredaki FE; Wright D; Matos P; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2011; 30(3):215-8. PubMed ID: 21952001
[TBL] [Abstract][Full Text] [Related]
16. Effect of chorionic villus sampling on serum alpha fetoprotein levels.
Edersheim TG; Thornton YS; Alonso ML; Kazam E
Am J Perinatol; 1985 Oct; 2(4):328-9. PubMed ID: 2413871
[TBL] [Abstract][Full Text] [Related]
17. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
[TBL] [Abstract][Full Text] [Related]
18. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
Spencer K; Bindra R; Cacho AM; Nicolaides KH
Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
[TBL] [Abstract][Full Text] [Related]
19. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
Aitken DA; Crossley JA
Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
[TBL] [Abstract][Full Text] [Related]
20. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
